Qrg Capital Management, Inc. Supernus Pharmaceuticals, Inc. Transaction History
Qrg Capital Management, Inc.
- $11.5 Trillion
- Q2 2025
A detailed history of Qrg Capital Management, Inc. transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Qrg Capital Management, Inc. holds 18,892 shares of SUPN stock, worth $779,106. This represents 0.01% of its overall portfolio holdings.
Number of Shares
18,892
Previous 17,583
7.44%
Holding current value
$779,106
Previous $576 Million
3.41%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding SUPN
# of Institutions
308Shares Held
60.1MCall Options Held
8.8KPut Options Held
6.3K-
Black Rock Inc. New York, NY10.4MShares$429 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.21MShares$256 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.2MShares$214 Million2.59% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.02MShares$125 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.7MShares$111 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $2.21B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...